CT694 and pgp3 as Serological Tools for Monitoring Trachoma Programs

BACKGROUND: Defining endpoints for trachoma programs can be a challenge as clinical signs of infection may persist in the absence of detectable bacteria. Antibody-based tests may provide an alternative testing strategy for surveillance during terminal phases of the program. Antibody-based assays, in...

Descripción completa

Detalles Bibliográficos
Autores principales: Goodhew, E. Brook, Priest, Jeffrey W., Moss, Delynn M., Zhong, Guangming, Munoz, Beatriz, Mkocha, Harran, Martin, Diana L., West, Sheila K., Gaydos, Charlotte, Lammie, Patrick J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486877/
https://www.ncbi.nlm.nih.gov/pubmed/23133684
http://dx.doi.org/10.1371/journal.pntd.0001873

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3486877/
https://www.ncbi.nlm.nih.gov/pubmed/23133684
http://dx.doi.org/10.1371/journal.pntd.0001873

Ejemplares similares